Sox17 inhibits hepatocellular carcinoma progression by downregulation of KIF14 expression

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11199-11207

  Yang, Tao ^a   Li, Xiao Na ^b   Li, Li ^a   Wu, Qi Mei ^a   Gao, Peng Zhi ^a   Wang, Hong Lei ^a   Zhao, Wei ^a  

^a FIRST HOSPITAL OF SHIJIAZHUANG   (China)

^b General Surgery Sports Science Institute of Hebei Province   (China)

Author keywords

Hepatocellular carcinoma; KIF14; SOX17

Indexed keywords

KIF14 PROTEIN, HUMAN; KINESIN; LUCIFERASE; MESSENGER RNA; ONCOPROTEIN; SMALL INTERFERING RNA; SOX17 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADULT; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DISEASE COURSE; FEMALE; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADULT; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DISEASE PROGRESSION; FEMALE; HUMANS; KINESIN; LIVER NEOPLASMS; LUCIFERASES; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SOXF TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84927788564     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2398-7     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.
3. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545–59.
4. Kern MA, Breuhahn K, Schirmacher P. Molecular pathogenesis of human hepatocellular carcinoma. Adv Cancer Res. 2002;86:67–112.
5. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–46.
6. Kim I, Saunders TL, Morrison SJ. Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells. Cell. 2007;130:470–83.
7. Park KS, Wells JM, Zorn AM, Wert SE, Whitsett JA. Sox17 influences the differentiation of respiratory epithelial cells. Dev Biol. 2006;294:192–202.
8. Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, et al. Identification of sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci Off J Soc Neurosci. 2006;26:9722–35.
9. Matsui T, Kanai-Azuma M, Hara K, Matoba S, Hiramatsu R, Kawakami H, et al. Redundant roles of sox17 and sox18 in postnatal angiogenesis in mice. J Cell Sci. 2006;119:3513–26.
10. Nakajima-Takagi Y, Osawa M, Oshima M, Takagi H, Miyagi S, Endoh M, et al. Role of sox17 in hematopoietic development from human embryonic stem cells. Blood. 2013;121:447–58.
11. Choi E, Kraus MR, Lemaire LA, Yoshimoto M, Vemula S, Potter LA, et al. Dual lineage-specific expression of sox17 during mouse embryogenesis. Stem Cells. 2012;30:2297–308.
12. Zhang W, Glockner SC, Guo M, Machida EO, Wang DH, Easwaran H, et al. Epigenetic inactivation of the canonical wnt antagonist sry-box containing gene 17 in colorectal cancer. Cancer Res. 2008;68:2764–72.
13. Liu Y, Asakura M, Inoue H, Nakamura T, Sano M, Niu Z, et al. Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. Proc Natl Acad Sci U S A. 2007;104:3859–64.
14. Fu DY, Wang ZM, Li C, Wang BL, Shen ZZ, Huang W, et al. Sox17, the canonical wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Breast Cancer Res Treat. 2010;119:601–12.
15. Jia Y, Yang Y, Liu S, Herman JG, Lu F, Guo M. Sox17 antagonizes wnt/beta-catenin signaling pathway in hepatocellular carcinoma. Epigenetics Off J DNA Methylation Soc. 2010;5:743–9.
16. Yang H, Lee S, Kim K, Yang Y, Kim JH, Adams RH, et al. Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice. J Clin Invest. 2013;123:418–31.
17. Yin D, Jia Y, Yu Y, Brock MV, Herman JG, Han C, et al. Sox17 methylation inhibits its antagonism of wnt signaling pathway in lung cancer. Discov Med. 2012;14:33–40.
18. Combes P, Planche V, Eymard-Pierre E, Sarret C, Rodriguez D, Boespflug-Tanguy O, et al. Relevance of sox17 variants for hypomyelinating leukodystrophies and congenital anomalies of the kidney and urinary tract (cakut). Ann Hum Genet. 2012;76:261–7.
19. Ye YW, Wu JH, Wang CM, Zhou Y, Du CY, Zheng BQ, et al. Sox17 regulates proliferation and cell cycle during gastric cancer progression. Cancer Lett. 2011;307:124–31.
20. Oishi Y, Watanabe Y, Yoshida Y, Sato Y, Hiraishi T, Oikawa R, et al. Hypermethylation of sox17 gene is useful as a molecular diagnostic application in early gastric cancer. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2012;33:383–93.
21. Hirokawa N, Noda Y, Tanaka Y, Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol. 2009;10:682–96.
22. Miki H, Okada Y, Hirokawa N. Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol. 2005;15:467–76.
23. Rath O, Kozielski F. Kinesins and cancer. Nat Rev Cancer. 2012;12:527–39.
24. Yu Y, Feng YM. The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy. Cancer. 2010;116:5150–60.
25. Carleton M, Mao M, Biery M, Warrener P, Kim S, Buser C, et al. RNA interference-mediated silencing of mitotic kinesin kif14 disrupts cell cycle progression and induces cytokinesis failure. Mol Cell Biol. 2006;26:3853–63.
26. Ahmed SM, Theriault BL, Uppalapati M, Chiu CW, Gallie BL, Sidhu SS, et al. Kif14 negatively regulates rap1a-radil signaling during breast cancer progression. J Cell Biol. 2012;199:951–67.
27. Gruneberg U, Neef R, Li X, Chan EH, Chalamalasetty RB, Nigg EA, et al. Kif14 and citron kinase act together to promote efficient cytokinesis. J Cell Biol. 2006;172:363–72.
28. Madhavan J, Coral K, Mallikarjuna K, Corson TW, Amit N, Khetan V, et al. High expression of kif14 in retinoblastoma: association with older age at diagnosis. Invest Ophthalmol Vis Sci. 2007;48:4901–6.
29. Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, Gallie BL. Kif14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2007;13:3229–34.
30. Corson TW, Gallie BL. Kif14 mrna expression is a predictor of grade and outcome in breast cancer. Int J Cancer J Int du Cancer. 2006;119:1088–94.
31. Theriault BL, Pajovic S, Bernardini MQ, Shaw PA, Gallie BL. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer. Int J Cancer J int du Cancer. 2012;130:1844–54.
32. Wang Q, Wang L, Li D, Deng J, Zhao Z, He S, et al. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients. Cancer Epidemiol. 2013;37:79–84.
33. Madhavan J, Mitra M, Mallikarjuna K, Pranav O, Srinivasan R, Nagpal A, et al. Kif14 and e2f3 mrna expression in human retinoblastoma and its phenotype association. Mol Vis. 2009;15:235–40.
34. Yang T, Zhang XB, Zheng ZM. Suppression of kif14 expression inhibits hepatocellular carcinoma progression and predicts favorable outcome. Cancer Sci. 2013;104:552–7.
35. Kim TM, Yim SH, Shin SH, Xu HD, Jung YC, Park CK, et al. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer J Int du Cancer. 2008;123:2808–15.
36. Marinescu VD, Kohane IS, Riva A. Mapper: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics. 2005;6:79.
37. Corson TW, Huang A, Tsao MS, Gallie BL. Kif14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene. 2005;24:4741–53.
38. Theriault BL, Basavarajappa HD, Lim H, Pajovic S, Gallie BL, Corson TW. Transcriptional and epigenetic regulation of kif14 overexpression in ovarian cancer. PLoS One. 2014;9:e91540.
39. Du YC, Oshima H, Oguma K, Kitamura T, Itadani H, Fujimura T, et al. Induction and down-regulation of sox17 and its possible roles during the course of gastrointestinal tumorigenesis. Gastroenterology. 2009;137:1346–57.
40. Wu Y, Li J, Sun CY, Zhou Y, Zhao YF, Zhang SJ. Epigenetic inactivation of the canonical wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells. Neoplasma. 2012;59:326–32.